109 related articles for article (PubMed ID: 1979661)
1. Ventricular fluid neuropeptides in Parkinson's disease. I. Levels and distribution of somatostatin-like immunoreactivity.
Jost S; Reuner C; Mohadjer M; Mundinger F; Cramer H
Neuropeptides; 1990 Apr; 15(4):219-25. PubMed ID: 1979661
[TBL] [Abstract][Full Text] [Related]
2. Ventricular somatostatin-like immunoreactivity in patients with basal ganglia disease.
Cramer H; Wolf A; Rissler K; Weigel K; Ostertag C
J Neurol; 1985; 232(4):219-22. PubMed ID: 2864402
[TBL] [Abstract][Full Text] [Related]
3. CSF somatostatin-like immunoreactivity in dementia.
Beal MF; Growdon JH; Mazurek MF; Martin JB
Neurology; 1986 Feb; 36(2):294-7. PubMed ID: 2868429
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa.
Strittmatter M; Hamann GF; Strubel D; Cramer H; Schimrigk K
J Neural Transm (Vienna); 1996; 103(5):591-602. PubMed ID: 8811504
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin-like immunoreactivity in cerebroventricular fluid of patients with basal midline tumours.
Cramer H; Weigel K; Rissler K; Milos A; Wolf A; Mundinger F
Neurol Res; 1987 Sep; 9(3):205-10. PubMed ID: 2891071
[TBL] [Abstract][Full Text] [Related]
6. Molecular size distribution of somatostatin-like immunoreactivity in the cerebroventricular fluid of neurosurgical patients.
Rissler K; Jost S; Mohadjer M; Mundinger F; Cramer H
Neurosci Res; 1987 Jun; 4(5):343-56. PubMed ID: 3670743
[TBL] [Abstract][Full Text] [Related]
7. CSF cyclic nucleotides and somatostatin in Parkinson's disease.
Volicer L; Beal MF; Direnfeld LK; Marquis JK; Albert ML
Neurology; 1986 Jan; 36(1):89-92. PubMed ID: 2867490
[TBL] [Abstract][Full Text] [Related]
8. Ventricular fluid neuropeptides in Parkinson's disease. II. Levels of substance P-like immunoreactivity.
Cramer H; Jost S; Reuner C; Milios E; Geiger J; Mundinger F
Neuropeptides; 1991 Feb; 18(2):69-73. PubMed ID: 1708113
[TBL] [Abstract][Full Text] [Related]
9. Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease.
Rissler K; Cramer H; Schaudt D; Strubel D; Gattaz WF
Neurosci Res; 1986 Feb; 3(3):213-25. PubMed ID: 2871533
[TBL] [Abstract][Full Text] [Related]
10. Human cerebrospinal fluid somatostatin in neurologic disease.
Beal MF; Mazurek MF; Black PM; Martin JB
J Neurol Sci; 1985 Nov; 71(1):91-104. PubMed ID: 2868070
[TBL] [Abstract][Full Text] [Related]
11. Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
Strittmatter M; Cramer H; Reuner C; Strubel D; Hamann G; Schimrigk K
Biol Psychiatry; 1997 Jun; 41(11):1124-30. PubMed ID: 9146823
[TBL] [Abstract][Full Text] [Related]
12. Substance P-like immunoreactivity and somatostatin-like immunoreactivity in the ventricular fluid of patients with chronic pain syndromes.
Jost S; Reuner C; Geiger J; Mohadjer M; Milios E; Cramer H
Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):109-12. PubMed ID: 1834180
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.
Cramer H; Schaudt D; Rissler K; Strubel D; Warter JM; Kuntzmann F
J Neurol; 1985; 232(6):346-51. PubMed ID: 2416886
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid (CSF) neuropeptide Y- and somatostatin-like immunoreactivities in man.
Maeda K; Yasuda M; Kaneda H; Maeda S; Yamadori A
Neuropeptides; 1994 Dec; 27(6):323-32. PubMed ID: 7898640
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactive substance P and somatostatin in the cerebrospinal fluid of senile parkinsonian patients.
Cramer H; Rissler K; Rösler N; Strubel D; Schaudt D; Kuntzmann F
Eur Neurol; 1989; 29(1):1-5. PubMed ID: 2468498
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.
Jolkkonen J; Soininen H; Halonen T; Ylinen A; Laulumaa V; Laakso M; Riekkinen P
J Neurol Neurosurg Psychiatry; 1986 Dec; 49(12):1374-7. PubMed ID: 2433403
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin-like immunoreactivity in cerebrospinal fluid of patients with complex partial epilepsy.
Pitkänen A; Jolkkonen J; Aikiä M; Sirviö J; Sivenius J; Riekkinen PJ
Eur Neurol; 1988; 28(1):1-5. PubMed ID: 3366146
[TBL] [Abstract][Full Text] [Related]
18. CSF somatostatin-like immunoreactivity in dementia of Parkinson's disease.
Poewe W; Benke T; Karamat E; Schelosky L; Wagner M; Sperk G
J Neurol Neurosurg Psychiatry; 1990 Dec; 53(12):1105-6. PubMed ID: 1981375
[No Abstract] [Full Text] [Related]
19. Cerebrospinal fluid somatostatin in delirium.
Koponen H; Stenbäck U; Mattila E; Reinikainen K; Soininen H; Riekkinen PJ
Psychol Med; 1989 Aug; 19(3):605-9. PubMed ID: 2572025
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy.
Masson H; Popescu I; Strubel D; Cramer H; Kuntzmann F
J Am Geriatr Soc; 1990 Jan; 38(1):19-24. PubMed ID: 1688571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
